Searchable abstracts of presentations at key conferences in endocrinology

ea0085oc9.7 | Oral Communications 9 | BSPED2022

Liraglutide for the treatment of severe obesity in children: early experiences from a tier 3 paediatric weight management service

Hawton Katherine , Price-Drewett Olivia , Wenn Melanie , Fitzgerald Amy , Hamilton-Shield Julian , Giri Dinesh

Background: Liraglutide is a glucagon-like peptide analogue recently approved for use in children and young people for treating obesity. It is recommended for use within multidisciplinary weight management services, alongside dietetic and lifestyle interventions, in children over 12 years with severe obesity.Aim: To describe our experiences of using liraglutide in a tier 3 paediatric obesity service in a patient cohort who had previously failed to succes...